CATALYST
Catalyzing Access to New Prevention Products to Stop HIV
Catalyzing Access to New Prevention Products to Stop HIV (CATALYST) is MOSAIC’s flagship product introduction study. The study will provide and assess an enhanced service delivery package that includes oral PrEP, PrEP ring, and injectable cabotegravir. The package of products and services for PrEP will be provided to women* at PEPFAR delivery sites in Kenya, Lesotho, South Africa, Uganda and Zimbabwe. The CATALYST study will also use quality improvement methods to refine the program and identify a core package for delivering PrEP choice.
For any additional information or questions about CATALYST, please contact the Research Operations Group (ROG) at [email protected].
*For this study, the term “women” is inclusive of individuals assigned female at birth of any gender identity or individuals assigned male at birth who identify as women.
- CATALYST Study Overview
- CATALYST Study FAQ
- CATALYST Study Implementation Materials
- Training Materials
- CATALYST Protocol—coming soon!
- Study-Specific Procedures (SSP) Manual—coming soon!
- Sample Informed Consent Forms—coming soon!
- Presentations – coming soon!
- Press Releases – coming soon!